A go-to-market mind, pointed at the body
Carine Carmy runs Origin, a women's health company that took a kind of physical therapy most people never knew to ask for and made it ordinary: covered by insurance, booked online, available in person across seven states and virtually in all fifty. In January 2026 she closed a Series B led by SJF Ventures. The headline number went undisclosed, which is its own kind of confidence.
Her job title says CEO. Her actual craft is distribution. Carmy spent a decade learning how to get useful things into the hands of people who want them, first in consulting, then at a 3D printing company, then at a healthcare cost-transparency startup. Origin is the same discipline aimed at a category that did not have a category. The pitch is plain: build clinics that are good and profitable, wrap them in software, and let a patient in any zip code reach a specialist without a referral safari.
In the future we're not going to call it telehealth. We're going to call it healthcare.
When the clinics closed, the company didn't
March 2020 was supposed to be the end of an in-person business. Carmy's team treated it as a deadline instead. They shipped a telehealth product in 48 hours and moved the majority of the next month's visits online. The clinics reopened. The virtual line never went away. What looked like a survival hack turned into the thing that now reaches every state.
This is the Carmy pattern: a constraint shows up, and she ships through it rather than waiting for it to lift. She is candid that the work runs on frustration. "I spend a lot of time being angry," she told TechCrunch, before adding that she is still hopeful. The anger is structural, aimed at a medical system that overlooks half its patients. The hope is operational, aimed at fixing it one booked appointment at a time.
Origin's reach, in plain numbers
Penn economics, then a detour through 3D printers
Carmy studied economics at the University of Pennsylvania, graduating in 2008. Before that she did research for The Milken Institute and Penn's Center for Bioethics, the early signal of someone who liked the seam where science, money, and policy meet. She started in management consulting at Monitor Deloitte, then in 2009 helped spin out Marketspace, a boutique digital strategy firm.
The resume reads like a series of unrelated bets until you notice the through-line. At Shapeways she ran marketing for a 3D printing service, learning how to sell people on a technology they had never used. At Amino she ran sales and marketing for a healthcare financial wellness platform, learning how opaque medical pricing keeps people from care they are entitled to. Origin is what happens when those two lessons collide: a clinical service most people do not know exists, blocked mostly by access rather than science.
She has also written about it. Her byline has run in MIT Technology Review, Forbes, Ad Age, and PSFK. She is the rare founder who can both build the funnel and write the essay explaining why it matters.
Now profitability is sexy. We've always wanted our locations to be profitable.
Two friends, one practice, a third co-founder who happened to be married to the second
Origin did not begin in a garage. It began with a partnership. Carmy and her longtime friend Nona Farahnik Yadegar joined forces in 2018, building on the Los Angeles practice Bebe Physical Therapy rather than starting a clinic from zero. Nona's husband, David Yadegar, came on as the third co-founder. The structure is unusual and tells you something about how Carmy operates: find what already works, then add the distribution layer the founders alone could not.
Early backers were a who's-who of operators who knew the access problem firsthand: Assaf Wand of Hippo, Jenny Fleiss of Rent the Runway, Josh Zad of Alfred. By the 2026 Series B the cap table had grown to include SJF Ventures, the Blue Venture Fund, Gratitude Railroad, and angels like Modern Fertility founder Afton Vechery and wellness entrepreneur Hannah Bronfman. Investors who build things, backing a founder who ships them.
A decade of data, now wearing the name Athena
The newest piece of Origin is not a clinic. It is software. Athena is an AI clinical decision product built on longitudinal data from 39 million patient interactions gathered over more than a decade. Origin has partnered with OpenAI since 2023 to build it. The logic is the same distribution instinct in a new outfit: a specialist's judgment, captured and scaled, so the quality of care does not depend on which clinic you happened to walk into.
Meanwhile Origin University trained more than 100 physical therapists and assistants in 2025, more than doubling the prior year. Carmy is building two supply lines at once, human and machine, betting that demand for this care was never the problem. Supply was.
She writes poetry and hosts dinner parties with her husband. The CEO has a soft side and a stocked kitchen.
She runs outdoors as a regular habit. The endurance shows up in how she runs the company too.
Her undergraduate research was for The Milken Institute and a bioethics center. The policy bug came early.
Her co-founders are a married couple. Origin runs on friendship as much as a cap table.
The Carmy file
I spend a lot of time being angry, but I'm still hopeful. Gender bias in medicine is systemic.
We launched a telehealth product in 48 hours.
So much of what we offer can be done remotely.
Now profitability is sexy. We've always wanted our locations to be profitable.
Where to hear her think out loud
Carmy is a regular on operator and health-tech podcasts, where the go-to-market detail comes through better than any press release. Good starting points: her episode on Leerink Partners' podcast and the Rosenman Institute's Health Technology Podcast, both linked below.